{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:53:15Z","timestamp":1762509195568,"version":"3.40.5"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"DOI":"10.1007\/s12094-024-03778-w","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T03:02:32Z","timestamp":1730775752000},"page":"2750-2760","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Different approach to M descriptor for future staging of oligometastatic disease in SCLC: A cross-sectional survival analysis"],"prefix":"10.1007","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8309-9517","authenticated-orcid":false,"given":"Melahat","family":"Uzel \u015eener","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4087-7048","authenticated-orcid":false,"given":"P\u0131nar","family":"Ak\u0131n Kabalak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5856-4891","authenticated-orcid":false,"given":"Suna","family":"Kavurgac\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6160-3778","authenticated-orcid":false,"given":"Nilg\u00fcn","family":"Y\u0131lmaz Demirci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9304-216X","authenticated-orcid":false,"given":"Derya","family":"K\u0131z\u0131lg\u00f6z","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8931-5329","authenticated-orcid":false,"given":"Fazl\u0131","family":"Yan\u0131k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0400-9403","authenticated-orcid":false,"given":"Sinem","family":"Ermin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0507-0767","authenticated-orcid":false,"given":"Yasemin","family":"S\u00f6yler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5491-1219","authenticated-orcid":false,"given":"Yekta Altemur","family":"Karamustafao\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3711-3125","authenticated-orcid":false,"given":"Demet","family":"T\u00fcrkay Pakna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5768-7830","authenticated-orcid":false,"given":"Ahmet","family":"Dumanl\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1493-8385","authenticated-orcid":false,"given":"\u00dclk\u00fc","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"3778_CR1","doi-asserted-by":"publisher","unstructured":"Nicholson AG, Chansky K, Crowley J, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the Clinical and Pathologic Staging of Small Cell Lung Cancer in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer.\u00a0J Thorac Oncol. 2016;11(3):300\u2013311. https:\/\/doi.org\/10.1016\/j.jtho.2015.10.008.","DOI":"10.1016\/j.jtho.2015.10.008"},{"issue":"1","key":"3778_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","volume":"7","author":"CM Rudin","year":"2021","unstructured":"Rudin CM, Brambilla E, Faivre-Finn C, Sage J. Small-cell lung cancer. Nat Rev Dis Primers. 2021;7(1):3. https:\/\/doi.org\/10.1038\/s41572-020-00235-0.","journal-title":"Nat Rev Dis Primers."},{"issue":"3","key":"3778_CR3","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/s0169-5002(02)00072-7","volume":"37","author":"P Micke","year":"2002","unstructured":"Micke P, Faldum A, Metz T, et al. Staging small cell lung cancer: veterans administration lung study group versus international association for the study of lung cancer\u2013what limits limited disease? Lung Cancer. 2002;37(3):271\u20136. https:\/\/doi.org\/10.1016\/s0169-5002(02)00072-7.","journal-title":"Lung Cancer"},{"issue":"8","key":"3778_CR4","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1007\/s11864-020-00762-8","volume":"21","author":"M Ragavan","year":"2020","unstructured":"Ragavan M, Das M. Systemic therapy of extensive stage small cell lung cancer in the era of immunotherapy. Curr Treat Options Oncol. 2020;21(8):64. https:\/\/doi.org\/10.1007\/s11864-020-00762-8.","journal-title":"Curr Treat Options Oncol."},{"issue":"23","key":"3778_CR5","doi-asserted-by":"publisher","first-page":"2220","DOI":"10.1056\/NEJMoa1809064","volume":"379","author":"L Horn","year":"2018","unstructured":"Horn L, Mansfield AS, Szcz\u0119sna A, et al. First-line atezolizumab plus chemotherapy in extensive-stage small-cell lung cancer. N Engl J Med. 2018;379(23):2220\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1809064.","journal-title":"N Engl J Med"},{"issue":"10212","key":"3778_CR6","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1016\/S0140-6736(19)32222-6","volume":"394","author":"L Paz-Ares","year":"2019","unstructured":"Paz-Ares L, Dvorkin M, Chen Y, et al. Durvalumab plus platinum-etoposide versus platinum-etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial. Lancet. 2019;394(10212):1929\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(19)32222-6.","journal-title":"Lancet"},{"issue":"9962","key":"3778_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(14)61085-0","volume":"385","author":"BJ Slotman","year":"2015","unstructured":"Slotman BJ, van Tinteren H, Praag JO, et al. Use of thoracic radiotherapy for extensive stage small-cell lung cancer: a phase 3 randomised controlled trial [published correction appears in Lancet. Lancet. 2015;385(9962):36\u201342. https:\/\/doi.org\/10.1016\/S0140-6736(14)61085-0.","journal-title":"Lancet."},{"issue":"1","key":"3778_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1200\/JCO.1995.13.1.8","volume":"13","author":"S Hellman","year":"1995","unstructured":"Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8\u201310. https:\/\/doi.org\/10.1200\/JCO.1995.13.1.8.","journal-title":"J Clin Oncol"},{"issue":"12","key":"3778_CR9","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S1470-2045(16)30532-0","volume":"17","author":"DR Gomez","year":"2016","unstructured":"Gomez DR, Blumenschein GR Jr, Lee JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17(12):1672\u201382. https:\/\/doi.org\/10.1016\/S1470-2045(16)30532-0.","journal-title":"Lancet Oncol"},{"issue":"18","key":"3778_CR10","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1200\/JCO.19.00201","volume":"37","author":"DR Gomez","year":"2019","unstructured":"Gomez DR, Tang C, Zhang J, et al. Local consolidative therapy Vs. maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer: long-term results of a multi-institutional, Phase II, Randomized Study. J Clin Oncol. 2019;37(18):1558\u201365. https:\/\/doi.org\/10.1200\/JCO.19.00201.","journal-title":"J Clin Oncol."},{"issue":"1","key":"3778_CR11","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2017.3501","volume":"4","author":"P Iyengar","year":"2018","unstructured":"Iyengar P, Wardak Z, Gerber DE, et al. Consolidative radiotherapy for limited metastatic non-small-cell lung cancer: a Phase 2 Randomized Clinical Trial. JAMA Oncol. 2018;4(1): e173501. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3501.","journal-title":"JAMA Oncol"},{"issue":"10185","key":"3778_CR12","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","volume":"393","author":"DA Palma","year":"2019","unstructured":"Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet. 2019;393(10185):2051\u20138. https:\/\/doi.org\/10.1016\/S0140-6736(18)32487-5.","journal-title":"Lancet"},{"issue":"7","key":"3778_CR13","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jtho.2024.02.011","volume":"19","author":"R Rami-Porta","year":"2024","unstructured":"Rami-Porta R, Nishimura KK, Giroux DJ, et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J Thorac Oncol. 2024;19(7):1007\u201327. https:\/\/doi.org\/10.1016\/j.jtho.2024.02.011.","journal-title":"J Thorac Oncol"},{"issue":"1","key":"3778_CR14","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/S1470-2045(19)30718-1","volume":"21","author":"M Guckenberger","year":"2020","unstructured":"Guckenberger M, Lievens Y, Bouma AB, et al. Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation. Lancet Oncol. 2020;21(1):e18\u201328. https:\/\/doi.org\/10.1016\/S1470-2045(19)30718-1.","journal-title":"Lancet Oncol"},{"key":"3778_CR15","doi-asserted-by":"publisher","unstructured":"Planchard D, Popat S, Kerr K, et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [published correction appears in Ann Oncol. 2019;30(5):863\u2013870. https:\/\/doi.org\/10.1093\/annonc\/mdy474].\u00a0Ann Oncol. 2018;29(Suppl 4):iv192\u2013iv237. https:\/\/doi.org\/10.1093\/annonc\/mdy275.","DOI":"10.1093\/annonc\/mdy474"},{"key":"3778_CR16","doi-asserted-by":"publisher","first-page":"715","DOI":"10.3389\/fonc.2020.00715","volume":"10","author":"X Wang","year":"2020","unstructured":"Wang X, Wang Z, Pan J, et al. Patterns of extrathoracic metastases in different histological types of lung cancer. Front Oncol. 2020;10:715. https:\/\/doi.org\/10.3389\/fonc.2020.00715.","journal-title":"Front Oncol."},{"issue":"14","key":"3778_CR17","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.2217\/fon-2017-0706","volume":"14","author":"H Cai","year":"2018","unstructured":"Cai H, Wang H, Li Z, Lin J, Yu J. The prognostic analysis of different metastatic patterns in extensive-stage small-cell lung cancer patients: a large population-based study. Future Oncol. 2018;14(14):1397\u2013407. https:\/\/doi.org\/10.2217\/fon-2017-0706.","journal-title":"Future Oncol"},{"issue":"6","key":"3778_CR18","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/1759-7714.13854","volume":"12","author":"Z Megyesfalvi","year":"2021","unstructured":"Megyesfalvi Z, Tallosy B, Pipek O, et al. The landscape of small cell lung cancer metastases: organ specificity and timing. Thorac Cancer. 2021;12(6):914\u201323. https:\/\/doi.org\/10.1111\/1759-7714.13854.","journal-title":"Thorac Cancer"},{"issue":"7","key":"3778_CR19","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1200\/JCO.1999.17.7.2092","volume":"17","author":"B Jeremic","year":"1999","unstructured":"Jeremic B, Shibamoto Y, Nikolic N, et al. Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer: a randomized study. J Clin Oncol. 1999;17(7):2092\u20139. https:\/\/doi.org\/10.1200\/JCO.1999.17.7.2092.","journal-title":"J Clin Oncol"},{"key":"3778_CR20","doi-asserted-by":"publisher","unstructured":"Putora PM, Glatzer M, De Ruysscher D, et al. Consolidative thoracic radiotherapy in stage IV small cell lung cancer: Selection of patients amongst European IASLC and ESTRO experts [published correction appears in Radiother Oncol. 2019;141:332. https:\/\/doi.org\/10.1016\/j.radonc.2019.10.006].\u00a0Radiother Oncol. 2019;135:74\u201377. https:\/\/doi.org\/10.1016\/j.radonc.2019.02.010.","DOI":"10.1016\/j.radonc.2019.10.006"},{"issue":"4","key":"3778_CR21","doi-asserted-by":"publisher","first-page":"249","DOI":"10.6004\/jnccn.2204.0023","volume":"22","author":"GJ Riely","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS, et al. Non-small cell lung cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024;22(4):249\u201374. https:\/\/doi.org\/10.6004\/jnccn.2204.0023.","journal-title":"J Natl Compr Canc Netw."},{"issue":"12","key":"3778_CR22","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.jtho.2019.07.025","volume":"14","author":"AC Dingemans","year":"2019","unstructured":"Dingemans AC, Hendriks LEL, Berghmans T, et al. Definition of synchronous oligometastatic non-small cell lung cancer-a consensus report. J Thorac Oncol. 2019;14(12):2109\u201319. https:\/\/doi.org\/10.1016\/j.jtho.2019.07.025.","journal-title":"J Thorac Oncol"},{"issue":"4","key":"3778_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214599","volume":"14","author":"M Shirasawa","year":"2019","unstructured":"Shirasawa M, Fukui T, Kusuhara S, et al. Prognostic differences between oligometastatic and polymetastatic extensive disease-small cell lung cancer. PLoS One. 2019;14(4): e0214599. https:\/\/doi.org\/10.1371\/journal.pone.0214599.","journal-title":"PLoS One."},{"key":"3778_CR24","doi-asserted-by":"publisher","unstructured":"Fong KM, Rosenthal A, Giroux DJ, et al. The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.\u00a0J Thorac Oncol. 2024;19(5):786\u2013802. https:\/\/doi.org\/10.1016\/j.jtho.2024.01.019","DOI":"10.1016\/j.jtho.2024.01.019"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03778-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12094-024-03778-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-024-03778-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T14:16:57Z","timestamp":1747405017000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12094-024-03778-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":24,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["3778"],"URL":"https:\/\/doi.org\/10.1007\/s12094-024-03778-w","relation":{},"ISSN":["1699-3055"],"issn-type":[{"type":"electronic","value":"1699-3055"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Ethical approval was obtained from the Ankara Atat\u00fcrk Chest Diseases and Surgery Training and Research Hospital Local Ethics Committee (21.01.2021\/710).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}